Aktuellt
SENASTE
Q3 sales of SEK 46m were above SEB (SEK 39m) with organic net sales decline of 24% y/y in the quarter. BPP sales and recurring licence revenues beat by 17% and 18%, respectively, with total revenues being 11% ahead. We note that contribution from Zimmer is a major delta (SEK 9m vs. SEBe at SEK 2m). Q3 EBITDA loss was SEK 10m (SEBe at SEK 23m). Bactiguard’s new financial targets call for sales of SEK 1bn and EBITDA of SEK 500m by 2028 (previously SEK 1bn for sales and SEK 400m for EBITDA by 2026).
LÄS MER
